Spread the love

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathanMiRNA-based Cancer therapeutics: MiRNA-382 increases the expression of the guardian of the genome p53  via down regulation of its target gene, 11/October/2014, 8.54 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests that miR-382, by suppressing the expression of its target gene, it may increase the transcription of tumor suppressor p53.  Furthermore, this study suggests a therapeutic strategy as to how human cancers with intact p53 can be treated. Together, pharmacological formulations encompassing “MiRNA-382 activators” may be used to treat human tumors with intact p53.

Spread the love